📉 Cipla Ltd (NSE: CIPLA) shares dropped 1.1% on 8 Jun 2026, closing at ₹1386.30.
📊 Market Snapshot
| Metric | Value |
|---|---|
| Open | ₹1397.00 |
| Close | ₹1386.30 |
| High | ₹1405.00 |
| Low | ₹1383.00 |
| Change | +1.07% (₹14.83) |
| Volume | 19,10,000 |
| Market Cap | ₹112000 Cr |
| 52W High | ₹1673.00 |
| 52W Low | ₹1165.70 |
🔍 Analysis
Cipla Ltd closed at ₹1386.3 on 8 June 2026, down 1.07% from its open of ₹1397. The drop occurred despite the stock trading at a volume of 19.10 L shares, exactly matching its 30‑day average, indicating no unusual buying or selling pressure. With no corporate announcements, regulatory updates, or macro news in the past 48 hours, the move appears driven by broader market sentiment. The Nifty 50 slipped 1.04% the same day, pulling the pharma sector lower as investors rotated out of riskier names amid a modest risk‑off mood. Cipla’s price is still about 17% below its 52‑week high of ₹1673 and roughly 19% above its 52‑week low of ₹1165.7, placing it in the lower‑mid range of its yearly trading band. The lack of a news catalyst, combined with average volume, suggests the decline is more a reflection of the overall market sell‑off rather than company‑specific concerns. Traders should keep an eye on upcoming pharma earnings releases and any policy news on drug pricing, as these could provide direction for Cipla in the next sessions.
🏷️ About Cipla Ltd
- Exchange: NSE
- Sector: Pharma
- Nifty Change: -1.04%
💡 For educational purposes only. Not financial advice.
Top comments (0)